Image For Activity Cover
Monograph: Myasthenia gravis and pregnancy
CME Available -
Myasthenia gravis (MG) is an autoimmune disorder with bimodal age of presentation, occurring in young women of reproductive age and at an older age in men. Occasionally, MG is diagnosed during pregnancy. Management of MG includes symptomatic treatment with cholinesterase inhibitors and immunosuppressive therapy for controlling the disease activity. Treatment of MG in women of reproductive age, who may be contemplating pregnancy, requires discussion regarding the choice of medication as well as the understanding of risks/adverse effects involved with various treatments. During the peripartum period, it is essential to ensure careful monitoring of the disease state along with the well‐being of the mother and fetus and to coordinate neonatal monitoring overseen by a multidisciplinary team comprising a high‐risk maternal fetal medicine specialist, a neurologist familiar with these complex issues, and a neonatologist.

The AANEM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

All conflicts of interest have been resolved according to ACCME standards. All authors/planners of this activity had nothing to disclose. 

The AANEM designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit expires 011/20/2023.
Kavita M. Grover MBBS, MD, Naganand Sripathi, MBBS, MD
Availability: On-Demand
Expires on Nov 20, 2023
Cost: Member: $0.00
Non-Member: $15.00
Credit Offered:
2 CME Credits
2 CEU Credits
2621 Superior Drive NW Rochester, MN 55901
Phone: 507.288.0100
Fax: 507.288.1225
Powered By